In HCC, activation of JAK2/STAT3 has been shown to increase matrix metalloproteinase 2 (MMP2), MMP9, and vascular endothelial growth factor (VEGF), promoting cell migration and invasion (60). The gene discussed is VEGFA; the disease is hepatocellular carcinoma.